Fortress Biotech
FBIO
Fortress Biotech (FBIO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.08
- EPS estimate
- −$0.20
- EPS surprise
- +60.00%
- Revenue surprise
- +2.28%
- Revenue
- $18.7M
- Revenue estimate
- $18.3M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.20 | −$0.08 | +60.00% | $18.7M | SEC |
| Q1 2026 | May 14, 2026 | −$0.22 | $2.82 | +1381.82% | $16.0M | SEC |
| Q4 2025 | Mar 31, 2026 | $0.11 | −$0.15 | −236.36% | $16.1M | SEC |
| Q3 2025 | Nov 14, 2025 | −$0.42 | $0.11 | +126.19% | $17.6M | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.36 | $0.45 | +225.00% | $16.4M | SEC |
| Q1 2025 | May 15, 2025 | −$0.50 | −$0.48 | +3.03% | $13.1M | SEC |
| Q4 2024 | Mar 31, 2025 | −$0.75 | −$0.17 | +77.43% | $15.1M | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.60 | −$0.76 | −27.73% | $14.6M | SEC |
| Q2 2024 | Aug 13, 2024 | −$1.22 | −$0.73 | +40.33% | $14.9M | SEC |
| Q1 2024 | May 15, 2024 | −$1.73 | −$1.03 | +40.46% | $13.0M | SEC |
| Q4 2023 | Mar 28, 2024 | −$1.65 | −$0.78 | +52.58% | $19.9M | SEC |
| Q3 2023 | Nov 14, 2023 | −$3.21 | −$0.94 | +70.68% | $34.8M | SEC |
| Q2 2023 | Aug 14, 2023 | −$3.41 | −$3.60 | −5.49% | $17.4M | SEC |
| Q1 2023 | May 15, 2023 | −$3.00 | −$3.15 | −5.00% | $12.4M | SEC |
| Q4 2022 | Mar 30, 2023 | −$3.33 | −$4.50 | −35.14% | $16.4M | SEC |
| Q3 2022 | Nov 14, 2022 | −$4.05 | −$3.75 | +7.41% | $16.5M | SEC |
| Q2 2022 | Aug 11, 2022 | −$2.81 | −$3.60 | −28.25% | $18.9M | SEC |
| Q1 2022 | May 12, 2022 | −$2.97 | −$2.70 | +9.09% | $23.9M | SEC |
| Q4 2021 | Mar 28, 2022 | $1.25 | −$5.70 | −556.00% | $18.3M | — |
| Q3 2021 | Nov 15, 2021 | −$1.23 | −$3.90 | −218.37% | $21.1M | — |
Quarterly revenue
Frequently asked questions
When did Fortress Biotech (FBIO) last report earnings?
Fortress Biotech last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did FBIO beat earnings estimates?
Yes. Fortress Biotech reported EPS of −$0.08 for Q2 2026 against a −$0.20 estimate — a 60.00% beat.
How much revenue did FBIO report last quarter?
Fortress Biotech reported $18.7M in revenue for Q2 2026, against a consensus estimate of $18.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.